Metastatic Esophageal Adenocarcinoma

Metastatic Esophageal Adenocarcinoma is the indication for 4 drugs in DrugBank. It is covered by 10 curated, structured indications.

Also known as: Oesophageal adenocarcinoma metastatic · Metastatic Adenocarcinoma of the Esophagus · metastatic Oesophageal Adenocarcinoma
Classified under: Digestive System Diseases
Neoplasms
Indicated drugs: Hyaluronidase (human recombinant)
Nivolumab
Tislelizumab
Zanidatamab

Resolves to

Vocabularies

MedDRA10058526

What you can answer from here — as of October 22, 2026

4Indicated drugsWith each drug's targets and mechanism

Listed above

10Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

12Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for Metastatic Esophageal Adenocarcinoma share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.